For decades, the burden of birth control has fallen primarily on women. From pills to IUDs to hormonal implants, the options have been wide—yet invasive, side-effect prone, and often expensive. Meanwhile, men have had just two choices: condoms or vasectomy. That may be about to change.
A wave of innovation is transforming the male contraceptive landscape, and one of the most promising developments is ADAM™, a breakthrough product from biotech company Contraline. Dubbed the “male IUD” by some, ADAM™ is a nonhormonal, reversible hydrogel implant injected directly into the vas deferens—the tube that carries sperm from the testicles to the urethra. This soft gel blocks sperm flow without affecting ejaculation, hormones, or sexual performance.
How it works:
The procedure is minimally invasive, completed in under 10 minutes using local anesthesia. The gel forms a barrier that prevents sperm from entering the semen, meaning fertilization is avoided. But unlike a vasectomy—which is considered permanent—ADAM™ is fully reversible, giving men long-term control without long-term commitment.
Contraline’s ADAM™ implant is currently in human clinical trials in the United States and Australia. Early results are promising, with the company aiming to provide a “set it and forget it” solution—similar in concept to an IUD, but tailored for male anatomy.
Not just gels: Hormonal male birth control is on the rise too
In parallel to nonhormonal options, scientists are making progress on hormonal male contraceptives as well. One promising method is a daily gel that combines segesterone acetate (Nestorone) with testosterone. This gel is applied to the shoulders and works by suppressing sperm production. In Phase 2 clinical trials, about 86% of men reached effective sperm suppression within just 8 weeks of daily use.
This method is also designed to be safe, reversible, and side-effect conscious—without affecting libido or long-term fertility.
Why now?
Recent shifts in global and local reproductive laws—particularly in the United States—have renewed public discussion around reproductive responsibility. Many men are expressing a desire to share that responsibility more equally.
Surveys show that nearly half of U.S. men say they would be open to trying new male contraceptives, and a large majority of women say they would trust their male partners to use them properly. In countries across Europe, Asia, and South America, male openness to contraception is even higher.
What this means for the future:
The rise of male birth control is more than just a scientific advancement—it’s a cultural shift. Products like the ADAM™ implant and hormonal gels could redefine how couples approach contraception, giving men more autonomy and women more peace of mind.
We’re approaching a future where birth control is no longer a one-sided conversation, but a shared responsibility backed by science, choice, and trust.
Samuga Media
Keeping you informed on the future of health, rights, and innovation.
